Pneumococcal polysaccharide vaccine 23-valent (Walvax Biotechnology)

23价肺炎球菌多糖疫苗（玉溪沃森）

Report date: 2026/05/20 20:02:01

Base Information

Drug NamePneumococcal polysaccharide vaccine 23-valent (Walvax Biotechnology)
Drug Alias Name23-valent pneumococcal polysaccharide vaccine - Walvax Biotechnology23-valent pneumococcal vaccine - Walvax BiotechnologyPneumococcal 23-valent polysaccharide vaccine - Walvax BiotechnologyPPV-23 - Walvax Biotechnology
ClassificationVaccines > National Immunization Program > Non-immunization program vaccine(Class II)Vaccines > Application > Prophylactic vaccineVaccines > Vaccine type > Multivalent vaccine +[4] 
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsPneumoniaPneumococcal Infections
Global Approved IndicationsPneumonia
Approved Indications in ChinaPneumonia
Original Approved Country/TerritoryMainland China
Original Approved Date2017/03/22
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesWalvax Biotechnology Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesWalvax Biotechnology Co Ltd
Inactive CompaniesN/A
Active IndicationsPneumonia
Inactive IndicationsPneumococcal Infections

Other Information

ATC CodeJ07AL01
Related LinksN/A